0000939767-21-000026.txt : 20210226 0000939767-21-000026.hdr.sgml : 20210226 20210226201056 ACCESSION NUMBER: 0000939767-21-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN CHARLES CENTRAL INDEX KEY: 0001202089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 21693122 MAIL ADDRESS: STREET 1: C/O ELELIXIR INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_161438823233506.xml FORM 4 X0306 4 2021-02-24 0 0000939767 EXELIXIS, INC. EXEL 0001202089 COHEN CHARLES C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 0 0 0 Common Stock 2021-02-24 4 M 0 40000 3.38 A 221375 D Common Stock 2021-02-24 4 S 0 40000 22.69 D 181375 D Option (right to buy) 3.38 2021-02-24 4 M 0 40000 0 D 2014-05-29 2021-05-28 Common Stock 40000.0 0 D Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.57 to $22.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2021-02-26